InsidersTradesSigma
HLB테라퓨틱스: management transactions · South Korea · DART (FSS)
DART:hlb-4201b7KR·DART (FSS)Mcap 264.9Bn€Healthcare
Browse the full insider trade history of HLB테라퓨틱스, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, HLB테라퓨틱스 has published 5 insider filings. Market capitalisation: €264.9bn. The latest transaction was reported on 21 April 2026 — Other. Among the most active insiders: HLB. All data is accessible without an account.
5
Insider Decl.
0
Thresholds
€1m
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3005.00 €
Analyst consensus
Income statement
Revenue69.56 Bn€
Gross profit10.17 Bn€15% margin
Net income−9.23 Bn€-13.3% margin
Valuation
Beta-0.63
Balance sheet & cash
Market cap264.91 Bn€
Total debt40.55 Bn€
Free Cash Flow−18.24 Bn€
Debt / Equity23%
Profitability & ownership
ROE-5.4%
ROA-1.0%
% insiders12.7%
% institutions1.0%
Last declaration on 21 April 2026
Declarations5 total
5 of 5 declarations